Werewolf Therapeutics, Inc. — Form 8-K
Filed August 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Werewolf Therapeutics filed an 8-K on 2026-08-20 reporting entry into a Material Definitive Agreement (Item 1.01) with period of report 2026-08-14. The filing contains only metadata and XBRL taxonomy files; the actual agreement details, counterparty identity, financial terms, dollar amounts, and business impact are not present in the provided excerpt.
Why this rating
Agreement described as 'material' by SEC definition but substance unavailable; cannot assess magnitude relative to $39.6M market cap without terms.
Extracted items
See more from August 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.